This inventor holds 3 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Momenta Pharmaceuticals, Inc.. Active years: 2015-2026.
Company Filing History:
Years Active: 2015-2026
Title: The Innovations of Inventor Enrique Arevalo
Introduction
Enrique Arevalo is a notable inventor based in Dorchester, MA (US). He has made significant contributions to the field of glycoprotein products, holding a total of 3 patents. His work focuses on the evaluation of glycoprotein preparations, which has implications in various biotechnological applications.
Latest Patents
One of his latest patents is titled "N-acetylhexosamine-containing N-glycans in glycoprotein products." This invention provides methods for evaluating a glycoprotein preparation for the absence, presence, or amount of an N-acetylhexosamine glycan, such as an N-acetylglucosamine glycan. This innovative approach enhances the understanding and quality of glycoprotein products in the industry.
Career Highlights
Enrique Arevalo is currently associated with Momenta Pharmaceuticals, Inc., where he applies his expertise in glycoprotein research. His work at the company has been instrumental in advancing the development of therapeutic products that utilize glycoproteins.
Collaborations
Throughout his career, Arevalo has collaborated with notable colleagues, including Nathaniel J Washburn and Kevin Millea. These collaborations have fostered a productive environment for innovation and research in the field of glycoproteins.
Conclusion
Enrique Arevalo's contributions to the field of glycoprotein products through his patents and work at Momenta Pharmaceuticals, Inc. highlight his role as an influential inventor. His innovative methods for evaluating glycoprotein preparations are paving the way for advancements in biotechnology.